Article
Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology.
Journal of inherited metabolic disease - 1 Jun 2007
Knerr I, Pearl P L, Bottiglieri T, Snead O Carter, Jakobs C, Gibson K M
Abstract excerpt
We overview the pathophysiological bases, clinical approaches and potential therapeutic options for succinate semialdehyde dehydrogenase (SSADH; EC1.2.1.24) deficiency (gamma-hydroxybutyric aciduria, OMIM 271980, 610045) in relation to studies on SSADH gene-deleted mice, outcome data developed fr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.